e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Telomere length in patients with unclassifiable interstitial lung disease: a cohort study
Brett Ley, Shuo Liu, Brett M. Elicker, Travis S. Henry, Eric Vittinghoff, Jeffrey A. Golden, Kirk D. Jones, Paul J. Wolters
Source:
Eur Respir J, 56 (2) 2000268; 10.1183/13993003.00268-2020
Journal Issue:
August
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Brett Ley, Shuo Liu, Brett M. Elicker, Travis S. Henry, Eric Vittinghoff, Jeffrey A. Golden, Kirk D. Jones, Paul J. Wolters. Telomere length in patients with unclassifiable interstitial lung disease: a cohort study. Eur Respir J, 56 (2) 2000268; 10.1183/13993003.00268-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
The new challenge of CTD-ILD: from basic science to clinical setting
Emerging classes of drugs for the treatment of obstructive lung disease
Related content which might interest you:
Diaphragm ultrasound in patients with interstitial lung disease (ILD): a prospective study.
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021
The association between leukocyte telomere length, telomere attrition and disease severity in cystic fibrosis patients
Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers
Year: 2017
Telomere length and genetic variant associations with interstitial lung disease progression and survival
Source: Eur Respir J, 53 (4) 1801641; 10.1183/13993003.01641-2018
Year: 2019
Outcomes of patients with progressive fibrosing interstitial lung disease (PF-ILD) – data from a prospective ILD registry
Source: Virtual Congress 2021 – The future of idiopathic pulmonary fibrosis
Year: 2021
Clinical characteristics of patients with unclassifiable interstitial lung disease
Source: International Congress 2015 – New insights into IIPs
Year: 2015
A single-centre retrospective study to phenotype unclassifiable interstitial lung disease
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020
A review of patients following a diagnosis of unclassified interstitial lung disease (ILD) at a tertiary centre
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020
Diffuse interstitial lung disease (a retrospective analysis of 79 cases)
Source: Eur Respir J 2002; 20: Suppl. 38, 61s
Year: 2002
A cohort of patients with a progressive fibrosing phenotype of interstitial lung disease (PF-ILD) other than idiopathic pulmonary fibrosis (IPF): the PROGRESS study
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Measuring patient activation in an interstitial lung disease (ILD) population: an exploratory study
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020
Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohort
Source: Eur Respir J, 55 (4) 1901694; 10.1183/13993003.01694-2019
Year: 2020
Gait speed and prognosis in patients with idiopathic pulmonary fibrosis: a prospective cohort study
Source: Eur Respir J, 53 (2) 1801186; 10.1183/13993003.01186-2018
Year: 2019
Body composition and mortality in idiopathic pulmonary fibrosis (IPF): a prospective cohort study.
Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation
Year: 2018
A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2014 – IPF and surroundings
Year: 2014
Frequency and characterization of sleep related disorders in interstitial lung disease patients: a prospective study
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017
PROOF-registry: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting
Source: International Congress 2014 – ILDs 6
Year: 2014
An observational study of incident diagnoses of children’s diffuse parenchymal lung disease (ChILDEU)
Source: International Congress 2018 – Primary ciliary dyskinesia and lung function tests in respiratory morbidities
Year: 2018
Final analysis of RECAP, an open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2016 – IPF treatment I
Year: 2016
Unraveling unclassifiable interstitial lung disease – a multicenter approach
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020
Risk factors for lung disease progression in children with cystic fibrosis; a longitudinal cohort study
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept